NSE ScannerChemicals · Chemicals: Specialty · NSE: AMAL · data 2026-10-31
Amal Ltd.
In plain words
Price: 50.9% below its 52-week high of ₹1,084.35.
Delivery: 35.8% of traded shares were kept for delivery over the last 10 sessions, against 57.7% over the last 52.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹366 cr |
| Net profit (last 12 months) | ₹30 cr |
| Sales growth, 3 years (yearly) | 57.5% |
| Profit growth, 3 years (yearly) | — |
At a glance
P/E 22.1, P/B 4.7, dividend yield 0.3%. Price relative to earnings and book value (low is cheaper, not better).
ROE 20.4%, ROCE 23.5%, operating margin 8.6%: how much profit it earns on the money it uses.
Debt/equity 0.00, Profit growth — and sales growth 57.5% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- High return on equity (20.4%).
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
23/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 18/30: Delivery 24.7% over the last 20 sessions vs 64.6% in the 40 before (0.38x); shares delivered per day 5.67x usual; 2 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Amal Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0, so it carries little or no borrowing on the balance sheet.
What is Amal Ltd.'s P/E ratio?
About 22.1, based on the last 12 months' earnings and a price of ₹532.65 (data 2026-10-31).
What is the 52-week high and low of Amal Ltd.?
The 52-week high is ₹1,084.35 and the 52-week low is ₹530.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Amal Ltd. | ₹532.65 | ₹660 cr | 22.1 | 4.7 | 20.4% | 23.5% | 0 | -30.1% |
| Transpek Industry Limited | ₹1,221.1 | ₹690 cr | 17.5 | — | 6% | 6.2% | 0.1 | +7.5% |
| Sadhana Nitro Chem Limited | ₹2.25 | ₹682 cr | — | 1.5 | -23.5% | -13.9% | 0.25 | +14.6% |
| Chemcon Speciality Chemicals Ltd | ₹181.84 | ₹673 cr | 22.2 | 1.4 | 4.8% | 3.9% | 0.11 | -28.6% |
| Kothari Petrochemicals Ltd. | ₹109.06 | ₹642 cr | 8.9 | — | 21.4% | 24.4% | 0.01 | -24.7% |
| Ganesh Benzoplast Limited | ₹88.07 | ₹634 cr | 8.7 | — | 12.6% | 11.6% | 0.12 | +2.0% |
Compare AMAL with TRANSPEK in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open AMAL in NSE Scanner →